Document Detail


Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed?
MedLine Citation:
PMID:  10695504     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Insertion of a mechanical artificial heart valve is an absolute indication for the use of lifelong oral anticoagulation, irrespective the presence or absence of atrial fibrillation. Depending on the type and position of the artificial valve the optimal International Normalized Ratio (INR) for these patients is between 2.5 and 4.5, although more prospective studies on the optimal range of oral anticoagulation are necessary. Addition of low dose antiplatelet therapy may further decrease the rate of thromboembolism, but also here more studies are needed. Patients with a bioprosthesis need only oral anticoagulation for the first three months following surgery in the absence of an indication for anticoagulation for other conditions. Atrial fibrillation is often seen in patients with artificial heart valves. Stroke prevention can be instituted by the mandatory oral anticoagulant therapy. The presence of atrial fibrillation and the use of oral anticoagulation prior to heart valve surgery support the indication for the insertion of a mechanical artificial heart valve. However, relative contraindications to oral anticoagulation and the presence of sinus rhythm may favor the use of a bioprosthesis.
Authors:
F W Verheugt
Related Documents :
18296394 - Apical rotating flow and right ventricular cerebral compression.
15132664 - Anticoagulant and antiplatelet agents: their clinical and device application(s) togethe...
8239824 - Clinical cardiopulmonary bypass without systemic anticoagulation.
16480434 - A hundred years of cascading - started by paul morawitz (1879-1936), a pioneer of haemo...
24999264 - Cardiac resynchronization in a patient with congenitally corrected transposition of the...
1703244 - The relationship between 24 hour total heart beats or ventricular arrhythmias and cardi...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  82 Suppl 1     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  1999 Sep 
Date Detail:
Created Date:  2000-03-22     Completed Date:  2000-03-22     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  130-5     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Heartcenter, University Hospital Nijmegen, The Netherlands. f.verheugt@cardio.azn.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / administration & dosage,  therapeutic use*
Atrial Fibrillation / etiology
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation* / adverse effects
Heart Valves / surgery*
Humans
Thrombosis / etiology,  prevention & control*
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism.
Next Document:  Platelet glycoprotein IIb/IIIa receptor blockade: lessening the risk of coronary interventions.